Is there an Advantage of Lymphadenectomy for Overall and Recurrence-Free Survival in Endometrial Carcinoma Type I FIGO IB G1-2? A Retrospective Population-Based Cohort Analysis

Hassas D, Papathemelis T, Gerken M, Scharl S, Scharl A, Lux MP, Beckmann M, Ortmann O, Klinkhamtner-Schalke M (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 90-90

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

Authors with CRIS profile

Matthias Beckmann Lehrstuhl für Geburtshilfe und Frauenheilkunde

Involved external institutions

Universität Regensburg DE Germany (DE) Klinikum St. Marien Amberg DE Germany (DE) Technische Universität München (TUM) DE Germany (DE) Universitätsklinikum Regensburg DE Germany (DE) Frauen- und Kinderklinik St. Louise DE Germany (DE)

How to cite

APA:

Hassas, D., Papathemelis, T., Gerken, M., Scharl, S., Scharl, A., Lux, M.P.,... Klinkhamtner-Schalke, M. (2020). Is there an Advantage of Lymphadenectomy for Overall and Recurrence-Free Survival in Endometrial Carcinoma Type I FIGO IB G1-2? A Retrospective Population-Based Cohort Analysis. In ONCOLOGY RESEARCH AND TREATMENT (pp. 90-90). BASEL: KARGER.

MLA:

Hassas, Dunja, et al. "Is there an Advantage of Lymphadenectomy for Overall and Recurrence-Free Survival in Endometrial Carcinoma Type I FIGO IB G1-2? A Retrospective Population-Based Cohort Analysis." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2020. 90-90.

BibTeX: Download